Express.co.uk [1] |
DIABETES TREATMENT OPERATION TRADES HANDS [2]
U-T San Diego Bristol-Myers Squibb, which bought Amylin Pharmaceuticals, a San Diego-based drugmaker, last year, is selling its entire diabetes business to partner AstraZeneca for up to $4.3 billion. AstraZeneca will pay $2.7 billion upfront and up to $1.4 billion … Astra's Diabetes Shot Won't Cure Growth Problems [3]Wall Street Journal AstraZeneca to Acquire Bristol Stake in Diabetes Venture [4]Businessweek AstraZeneca seals diabetes drug deal [1]Express.co.uk Fox Business [5] –RTT News [6] all 221 news articles » [7] |
More details can be found at www.diabeteshowto.com [8]